¸ð½Ã´Â±Û ÇÁ·Î±×·¥ ÃÊ·ÏÁ¢¼ö »çÀüµî·Ï ¹ßÇ¥ÀÚ ¾È³» ¹ßÇ¥ÀÚ ¾È³» Çà»çÀå¾È³» ¼÷¹Ú¾È³» Ȩ

ÀϹݿ¬Á¦ ¹ßÇ¥ À¯ÀÇ»çÇ×

ÀϹݿ¬Á¦ ¹ßÇ¥ÀÚ´Â ¹Ýµå½Ã ¹ßÇ¥ ½½¶óÀ̵å(ÆÄ¿öÆ÷ÀÎÆ®)¸¦ »çÀü¿¡ Á¦ÃâÇÏ¼Å¾ß ¹ßÇ¥°¡ °¡´ÉÇÕ´Ï´Ù.
½½¶óÀ̵带 ±âÇÑ ³»¿¡ Á¦ÃâÇÏÁö ¾ÊÀ» °æ¿ì¿¡´Â ¹ßÇ¥ºÒ°¡´ÉÀ¸·Î °£ÁÖÇÕ´Ï´Ù.
¹ßÇ¥ ½½¶óÀ̵å¼ö´Â 15¸Å À̳»·Î 1Àå ´ç 10ÁÙ À̳»·Î Á¦ÀÛÇϽô °ÍÀ» ±ÇÀåÇϸç, ÁöÁ¤µÈ 10ºÐ ¹ßÇ¥½Ã°£(8ºÐ ÅäÀÇ-2ºÐ ÁúÀÇÀÀ´ä)À» Á¤È®È÷ ÁöÄÑÁֽñ⠹ٶø´Ï´Ù.

1. ÆÄÀÏ Á¦Ã⸶°¨ÀÏ : 9¿ù 22ÀÏ (¿ù)
2. ÆÄÀÏ ÇüÅ : ÆÄ¿öÆ÷ÀÎÆ®
3. Á¦Ãâ ¹æ¹ý : ppt1@ksog.org

±¸¿¬ - Àüü   /    ¸ðüžÆÀÇÇР  /    »ý½Ä³»ºÐºñÇР  /    ºÎÀÎÁ¾¾çÇР  /    ÀϹݺÎÀΰúÇÐ

[ ±¸¿¬ - ¸ðüžÆÀÇÇÐ ]

2008³â 9¿ù 26ÀÏ(±Ý)

Convention Hall A (4F)
½Ã°£ ¹øÈ£ ¼º¸í ¼Ò¼Ó Á¦¸ñ
ÁÂÀå : ¹ÚÀ±±â(¿µ³²ÀÇ´ë)
12:30~13:10 OB1 ±èÈÖ°ï ºÎ»êÀÇ´ë Postnatal neovascularization in a mouse model via stem cells derived from human fetal amniotic membranes
OB2 °­¿µÈ­ °¡Å縯ÀÇ´ë Omcostatin M as a target biological molecule of preeclampsia
OB3 °ûµ¿¿í ¿¬¼¼ÀÇ´ë Leukocyte counts and differential distribution in preeclampsia
OB4 ÁÖº¸¼± ÁÁÀº¹®È­º´¿ø ºñ½ºÆ÷½ºÆ÷³×ÀÌÆ®°¡ Àΰ£ ¾ç¼öÀ¯·¡ Áß°£¿± Áٱ⼼Æ÷·ÎºÎÅÍ Á¶°ñ¼¼Æ÷¿Í Áö¹æ¼¼Æ÷·ÎÀÇ ºÐÈ­¿¡ ¹ÌÄ¡´Â ¿µÇâ
ÁÂÀå : ½ÅÁ¾Ã¶(°¡Å縯ÀÇ´ë)
13:10~13:50 OB5 À̼ø¾Ö °æ»óÀÇ´ë Omega-3 fatty acids increase PPAR¥ã activity and Suppress ET-1 in human umbilical vein endothelial cells
OB6 ¹éÀ¯Áø °í·ÁÀÇ´ë Effect of Interferon-gamma on VEGF expression of extravillous trophoblast in first trimester villous explant culture
OB7 ¾ÈÇö¿µ °¡Å縯ÀÇ´ë Human placental membrane : a extensive source for mesenchymal stem cells with differentiation into osteocyte, chondrocyte, and adipocyte in vitro
OB8 ÀÌÁ¤Çå ÀüºÏÀÇ´ë Molecular mechanism for actin cleavage in rat uterus during pregnancy
ÁÂÀå : Á¶¿ë±Õ(ÀÎÁ¦ÀÇ´ë)
13:50~14:30 OB9 ÇÑÀ¯Á¤ °üµ¿ÀÇ´ë Karyotype and outcome of fetuses with increased nuchal translucency above 99th percentile
OB10 ÀÌ°æ¾Æ ¼­¿ïÀÇ´ë ¸¸»è Àӽſ¡¼­ ¾ç¼ö³» ź¯ Âø»öÀÇ ºóµµ¿Í À§ÇèÀÎÀÚ
OB11 ¹Ú¹®ÀÏ ÇѾçÀÇ´ë ºñ¼öÃ༺°Ë»ç¿¡¼­ žƽɹڵ¿ Áõ°¡½Ã ÁøÆø(bpm) ¹× Áö¼Ó½Ã°£(sec)ÀÇ ÀÇÀÇ
OB12 ¹Ú¹®ÀÏ ÇѾçÀÇ´ë ºñ¼öÃ༺°Ë»ç(NST) Æǵ¶¿¡¼­ ÀüÅëÀû ¼±Çü(linear) ºÐ¼®¹æ¹ý ¹× ºñ¼±Çü(nonlinear)ºÐ¼®¹æ¹ýÀÇ ºñ±³
14:30~15:00   Coffee Break
ÁÂÀå : Á¤Àιè(¿¬¼¼ÀÇ´ë)
15:00~15:40 OB13 ÀÌÀÏÇÑ Áß¾ÓÀÇ´ë Usefulness of umbilical cord arterial blood lactate for assessment of fetal metabolic acidemia
OB14 ±èÀÇÇõ ±¹¹Î°Ç°­º¸Çè°ø´Ü Àϻ꺴¿ø ÁøÅë Áß ·¹¹ÌÆ柴Ò(remifentanyl)À» ÀÌ¿ëÇÑ »ê¸ðÀÇ ÅëÁõ Á¶Àý
OB15 ±èÁ¾¿î Àü³²ÀÇ´ë ±â¿ÕÁ¦¿ÕÀý°³¼ú ÀÓºÎÀÇ ÀӽŠÁ¦2»ïºÐ±â ÁßÀý¿¡¼­ Áú³» ¹Ì¼ÒÇÁ·Î½ºÅç Åõ¿©¿Í ¶ó¹Ì³ª¸®¾Æ »ðÀÔ ÈÄ ½ÃµµÀÇ À¯¿ë¼º ºñ±³
OB16 À̽ÿø °üµ¿ÀÇ´ë The maternal bone mineral density (BMD) at second trimester of pregnancy can reflect the fetal growth at birth
ÁÂÀå : ÀÌÇÊ·®(¿ï»êÀÇ´ë)
15:40~16:20 OB17 ÁöÇö¿µ ¼º±Õ°üÀÇ´ë Frequency and risk factors for subsequent diabetes after gestational diabetes mellitus
OB18 ¼Õ°¡Çö ¿¬¼¼ÀÇ´ë Maternal lipids as predictive factors for large for gestational age newborns in women with gestational diabetes mellitus
OB19 ±èÁöÀ± ÀÌÈ­ÀÇ´ë ÀÓ½ÅÀü üÁú·®Áö¼ö¿Í ÀÓ½ÅÁß Ã¼ÁßÁõ°¡°¡ ÀӽŰá°ú¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ °üÇÑ ¿¬±¸
OB20 ¹éÀ¯Áø °í·ÁÀÇ´ë 100g °æ±¸ ´çºÎÇÏ °Ë»ç¹ýÀÇ º¯ÇüÀ» ÅëÇÑ Àӽżº ´ç´¢º´ÀÇ Áø´Ü
ÁÂÀå : È«±â¿¬(¿ø±¤ÀÇ´ë)
16:20~17:00 OB21 ±è¿¬Èñ °¡Å縯ÀÇ´ë Association of haptoglobin polymorphism with premature rupture of membrane
OB22 °­ÁöÇö ¼­¿ïÀÇ´ë ÀڱðæºÎ ºÐºñ¹°³» ÅÂ¾Æ ÆÄÀ̺ê·Î³Øƾ: Á¶±â ÁøÅë »ê¸ð¿¡¼­ÀÇ ¾ç¼ö³» ¿°Áõ ¹× ÅÂ¹Ý ¿°Áõ, Á¶»êÀÇ ¿¹ÃøÀÎÀÚ
OB23 ±è¹Î±Õ ¿ï»êÀÇ´ë Progesterone modulation of interleukin 6 in uterine cervical fibroblast cells of pregnant women treated with lipopolysaccharide
OB24 ±è¹ÎÇü °üµ¿ÀÇ´ë Amniotic and cervical fluid hyaluronic acid levels at mid-trimester and spontaneous preterm delivery